Still hunting a blockbuster, Merck KGaA scores a win in the FDA approval column — more than 13 years in the making
Thirteen years after it was put on the FDA’s fast track, and 8 years after the agency spurned it in a direct rebuke for an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
